Table 1 (abstract P301). Data elements voted into the “Core cSLE Dataset” by consensus meeting participants (≥ 80% agreement)

Demographics

Date of birth, country of residence, sex, gender, ancestry, date of SLE symptom onset, date of SLE diagnosis, family history of SLE in a 1st degree relative

SLE Classification Criteria

2012 SLICC, 2019 EULAR/ACR

Visit Data

Blood pressure, height, weight, menarche status, menstrual cycle status

Disease Activity

SLEDAI-2K, physician global assessment, patient/parent global assessment

SLE-related Damage Index

SLICC Damage Index

Laboratory Tests

Complete blood count, c-reactive protein, erythrocyte sedimentation rate, ANA, ENA, dsDNA, antiphospholipid antibodies, C3/C4, IgG, creatinine, albumin, urine protein:creatinine, urine microscopy

Kidney Biopsy Data

ISN/RPS class, biopsy date (for each biopsy)

Medications

Steroids, immunomodulators, anti-hypertensives, lipid-lowering agents, anticoagulants, contraception, anti-depressants, anti-epileptics

Serious Adverse Events

Hospitalization, ESRD, dialysis, kidney transplant, pregnancy, malignancy, death